Summary:
Since 1997, autologous stem cell transplantation (ASCT) had been applied to more than 40 children with polyarticular or systemic juvenile idiopathic arthritis (JIA). For this review, results of the follow-up are available from 25 children with systemic JIA and six with polyarticular JIA that were reported in detail from eight different pediatric European transplant centers. Before ASCT all children had progressive disease despite the use of corticosteroids, methotrexate (MTX) up to 1 mg/kg/week, cyclosporin (2.5 mg/kg/day) and/or anti-TNFα therapy. The clinical follow-up of these children ranges from 8 to 60 months (median 33 months).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cassidy JT, Petty RE . Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds). Textbook of Pediatric Rheumatology. WB Saunders: Philadelphia, 2001, pp 218–322.
Wallace CA, Levinson JE . Outcome and treatment for the 1990s. Rheum Dis Clin North Am 1991; 17: 891–905.
Gare BA, Fasth A . A population based cohort study. I. Onset and disease process. J Rheumatol 1995; 22: 295–307.
Gare BA, Fasth A . A population based cohort study. II. Outcome. J Rheumatol 1995; 22: 308–319.
Lovell DJ, Giannini EH, Reiff A et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342: 763–769.
Joske DJ, Ma DT, Langlands DR, Owen ET . Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet 1997; 350: 337–338.
Moore J, Brooks P, Milliken S et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301–2309.
Tyndall A, Black C, Finke J et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997; 349: 254.
Traynor AE, Schroeder J, Rosa RM et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000; 356: 701–707.
Wulffraat NM, van Royen A, Bierings M et al. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999; 353: 550–553.
Giannini EH, Ruperto N, Ravelli A et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202–1209.
Ruperto N, Ravelli A, Falcini F et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998; 57: 38–41.
Singh G, Athreya BH, Fries JF, Goldsmith DP . Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761–1769.
Fuchs HA, Pincus T . Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994; 37: 470–475.
Len C, Ferraz MB, Goldenberg J et al. Pediatric Escola Paulista de Medicina Range of Motion Scale: a reduced joint count scale for general use in juvenile rheumatoid arthritis. J Rheumatol 1999; 26: 909–913.
Slaper-Cortenbach IC, Wijngaarden-du Bois MJ, Vries-van Rossen A et al. The depletion of T cells from haematopoietic stem cell transplants. Rheumatology (Oxford) 1999; 38: 751–754.
Vlieger AM, Brinkman DM, Quartier P et al. Infection associated macrophage activation syndrome in 3 patients receiving autologous stem cell transplantation (ASCT) for refractory JCA. Bone Marrow Transplant 2000; 25 (Suppl. 1): 81 (Abstract).
Quartier P, Prieur AM, Fischer A . Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet 1999; 353: 1885–1886.
Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease–feasibility and transplant–related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729–734.
Mouy R, Stephan JL, Pillet P et al. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129: 750–754.
Acknowledgements
Patient data were obtained from nine pediatric university centers in Europe. The clinical studies in the Netherlands were supported in part by a grant from the Dutch League against Rheumatism. LW was supported by a grant from SPARKS (Sport Aiding Medical Research for Kids).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wulffraat, N., Brinkman, D., Ferster, A. et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 32 (Suppl 1), S61–S64 (2003). https://doi.org/10.1038/sj.bmt.1703946
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703946